Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
Abstract Background Whether pre-diabetes in the absence of hypertension (HTN) or dyslipidemia (DLP) is a risk factor for occurrence of major adverse cardiovascular events (MACE) is not fully established. We investigated the effect of impaired fasting glucose (IFG) alone and in combination with HTN,...
Main Authors: | Nahid Hashemi Madani, Faramarz Ismail-Beigi, Hossein Poustchi, Mahdi Nalini, Sadaf G. Sepanlou, Mojtaba Malek, Mohammad Amin Abbasi, Alireza Khajavi, Mohammad E. Khamseh, Reza Malekzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-020-01390-8 |
Similar Items
-
Risk-factor profile for coronary artery disease among young and elderly patients in Andhra Pradesh
by: Srinivasa Jayachandra, et al.
Published: (2014-01-01) -
Role of dyslipidemia in preeclamptic overweight pregnant women
by: Seyede Hajar Sharami, et al.
Published: (2012-01-01) -
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
by: Jing-Lu Jin, et al.
Published: (2020-04-01) -
Dyslipidemia in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Centre: A Descriptive Cross-sectional Study
by: Ram Kumar Mehta, et al.
Published: (2021-04-01) -
Dyslipidemia in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Centre: A Descriptive Cross-sectional Study
by: Ram Kumar Mehta, et al.
Published: (2021-04-01)